| 000 | 01797 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514061425.0 | ||
| 264 | 0 | _c20030328 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.2003.05.155 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChristian, J A | |
| 245 | 0 | 0 |
_aIntensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMar 2003 |
||
| 300 |
_a871-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadverse effects |
| 650 | 0 | 4 |
_aGerminoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTesticular Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aHuddart, R A | |
| 700 | 1 | _aNorman, A | |
| 700 | 1 | _aMason, M | |
| 700 | 1 | _aFossa, S | |
| 700 | 1 | _aAass, N | |
| 700 | 1 | _aNicholl, E J | |
| 700 | 1 | _aDearnaley, D P | |
| 700 | 1 | _aHorwich, A | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 21 _gno. 5 _gp. 871-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2003.05.155 _zAvailable from publisher's website |
| 999 |
_c12406257 _d12406257 |
||